Editorial: Biomolecular modifications in endocrine-related cancers

Xianquan Zhan; Junwen Su; Lamei Yang

doi:10.3389/fendo.2023.1133629

Editorial: Biomolecular modifications in endocrine-related cancers

Front Endocrinol (Lausanne). 2023 Jan 13:14:1133629. doi: 10.3389/fendo.2023.1133629. eCollection 2023.

Authors

Xianquan Zhan¹, Junwen Su¹, Lamei Yang¹

Affiliation

¹ Medical Science and Technology Innovation Center, Shandong Key Laboratory of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong, China.

No abstract available

Keywords: DNA modifications; endocrine-related cancers; genomics; post-transcriptional modifications; post-translational modifications; proteoformics; proteomics; transcriptomics.

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Endocrine Gland Neoplasms* / genetics
Humans
Protein Processing, Post-Translational
Proteomics*

Grants and funding

This work was supported by the Shandong First Medical University Talent Introduction Funds (awarded to XZ), Shandong First Medical University High-level Scientific Research Achievement Cultivation Funding Program (awarded to XZ), Shandong Provincial Taishan Scholar Engineering Project Special Funds (awarded to XZ), the Shandong Provincial Natural Science Foundation (ZR2021MH156 to XZ), Shandong First Medical University Undergraduate Innovation Research Program (Project No.: 2022104391511), and the National Natural Science Foundation of China (82203592).